Synapse - Works

Results (352)

Multiple myeloma and comorbidity: A population-based study

Meeting Abstract

Sverrisdottir, I. S.; Rögnvaldsson, S.; Lund, S. H.; Turesson, I.; Hultcrantz, M.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2017)

Fulltext@MSK | Save

Variant FLT3 mutations can be eradicated by cytarabine/anthracycline/crenolanib induction in adult patients with newly diagnosed FLT3 (ITK/TKD) mutant AML

Meeting Abstract

Wang, E.; Stone, R.; Collins, R.; Agrawal, T.; Urity, V.; Tallman, M.
Haematologica (2017)

Fulltext@MSK | Save

Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD

Meeting Abstract

Gupta, D. M.; Devlin, D. S.; Tallman, D. M.; Stein, D. E.
Haematologica (2017)

Fulltext@MSK | Save

Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)

Meeting Abstract

Davids, M. S.; Roberts, A. W.; Seymour, J. F.; Wierda, W. G.; Puvvada, S. D.; Gressick, L.; Alter, D.; Zhou, L.; Kim, S. Y.; Verdugo, M.; more...
Haematologica (2017)

Fulltext@MSK | Save

Timing of defibrotide initiation post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after primary chemotherapy: Exploratory analysis of an expanded-access protocol

Meeting Abstract

Kernan, N.; Richardson, P.; Triplett, B.; Grupp, S.; Antin, J.; Liang, W.; Hume, R.; Tappe, W.; Soiffer, R.
Haematologica (2017)

Fulltext@MSK | Save

Defibrotide efficacy and safety in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) diagnosed after day 21: Analysis of final data from an expanded-access program

Meeting Abstract

Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; more...
Haematologica (2017)

Fulltext@MSK | Save

Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Final subgroup results

Meeting Abstract

Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
Haematologica (2017)

Fulltext@MSK | Save

Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy

Meeting Abstract

Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
Haematologica (2017)

Fulltext@MSK | Save

Phase 3 ALCANZA study of brentuximab vedotin (BV) or physician's choice (PC) of methotrexate (MTX) or bexarotene (Bex) in CD30-positive cutaneous T-cell lymphoma (CTCL): Number needed to treat analysis

Meeting Abstract

Zagadailov, E.; Prince, H. M.; Whittaker, S.; Horwitz, S.; Duvic, M.; Kim, Y.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; more...
Haematologica (2017)

Fulltext@MSK | Save

Prognostic tools can provide personalized outcomes prediction after allogeneic HCT in patients with hematologic malignancies

Meeting Abstract

Cho, C.; Devlin, S.; Hilden, P.; Maloy, M.; Horowitz, M.; Rizzo, J. D.; Logan, B.; Barba, P.; O'Reilly, R.; Giralt, S.; more...
Haematologica (2017)

Fulltext@MSK | Save